Siemens Biomarker Multi-modality
Purpose
The purpose of this study is to see how well Photon Counting CT (PCCT) and ultrasound test results can find fat and scarring in the liver. They will be compared to MRI test results as the reference standard. Participants will get a regular CT scan on the PCCT scanner, plus a few extra pictures just for the study. They will also get an MRI, either on the same day or a different day, whichever is preferred. Participants will get an ultrasound on the same day as the MRI. If they have not had a hematocrit blood test in the past 24 hours, they will also receive one on the day of the CT scan.
Conditions
- Fatty Liver
- Hepatic Steatosis
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Age of 18 years or older - Has clinically indicated CT schedule including the liver (with contrast or with and without contrast) - Patient eligible for MR imaging - History of chronic diffuse liver disease, steatotic liver disease, and/ or liver fibrosis - Capable of consent
Exclusion Criteria
- Contraindications to any of the required imaging examinations - BMI > 45 (based on MRI scanner capacity)
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Non-Randomized
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Diagnostic
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Active Comparator Photon Counting CT (PCCT) |
Participants will get a regular CT scan on the PCCT scanner, plus a few extra pictures just for the study. |
|
|
Active Comparator MRI |
Participants will get an MRI, either on the same day as the PCCT scan or a different day, whichever is preferred. |
|
|
Active Comparator Ultrasound |
Participants will get an ultrasound on the same day as the MRI. |
|
Recruiting Locations
Duke University Medical Center
Durham, North Carolina 27710
Durham, North Carolina 27710
More Details
- Status
- Recruiting
- Sponsor
- Duke University